Bvf Inc Ac Immune Sa Transaction History

Bvf Inc

$3.15 Billion
Q3 2024

A detailed history of Bvf Inc transactions in Ac Immune Sa stock. As of the latest transaction made, Bvf Inc holds 19,522,436 shares of ACIU stock, worth $69.3 Million. This represents 2.35% of its overall portfolio holdings.

Number of Shares

19,522,436

Previous 18,834,936 3.65%

Holding current value

$69.3 Million

Previous $75.2 Million 1.81%

% of portfolio

2.35%

Previous 2.3%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$2.99 - $4.2 $2.06 Million - $2.89 Million	687,500 Added 3.65%	19,522,436 $73.8 Million
Q2 2024 Aug 14, 2024	BUY	$2.29 - $4.87 $9.76 Million - $20.8 Million	4,263,700 Added 29.26%	18,834,936 $75.2 Million
Q4 2023 Feb 14, 2024	BUY	$2.46 - $5.0 $17.6 Million - $35.7 Million	7,142,857 Added 96.16%	14,571,236 $72.9 Million
Q1 2022 May 16, 2022	BUY	$3.5 - $5.16 $1.28 Million - $1.89 Million	366,000 Added 5.18%	7,428,379 $29.7 Million
Q4 2021 Feb 14, 2022	BUY	$4.83 - $7.56 $614,376 - $961,632	127,200 Added 1.83%	7,062,379 $35 Million
Q3 2021 Nov 15, 2021	SELL	$6.2 - $8.34 $9.98 Million - $13.4 Million	-1,610,000 Reduced 18.84%	6,935,179 $46.5 Million
Q2 2021 Aug 16, 2021	BUY	$6.04 - $8.37 $6.29 Million - $8.71 Million	1,040,600 Added 13.87%	8,545,179 $67.8 Million
Q1 2021 May 17, 2021	SELL	$5.32 - $8.96 $12.3 Million - $20.7 Million	-2,312,079 Reduced 23.55%	7,504,579 $57.1 Million
Q4 2020 Feb 12, 2021	SELL	$4.47 - $5.58 $9,387 - $11,718	-2,100 Reduced 0.02%	9,816,658 $50.8 Million
Q3 2020 Nov 13, 2020	SELL	$4.78 - $9.06 $7.17 Million - $13.6 Million	-1,500,000 Reduced 13.25%	9,818,758 $47.9 Million
Q2 2020 Aug 14, 2020	SELL	$6.57 - $8.3 $156,017 - $197,100	-23,747 Reduced 0.21%	11,318,758 $76.2 Million
Q4 2019 Feb 14, 2020	BUY	$4.56 - $8.78 $203,348 - $391,535	44,594 Added 0.39%	11,342,505 $96.6 Million
Q3 2019 Nov 14, 2019	BUY	$4.8 - $5.89 $7.1 Million - $8.71 Million	1,478,477 Added 15.06%	11,297,911 $55.9 Million
Q2 2019 Aug 14, 2019	BUY	$4.72 - $5.88 $11.2 Million - $13.9 Million	2,363,900 Added 31.71%	9,819,434 $54.5 Million
Q1 2019 May 15, 2019	BUY	$3.65 - $11.68 $19.1 Million - $61 Million	5,225,507 Added 234.32%	7,455,534 $37.7 Million
Q4 2018 Feb 14, 2019	BUY	$7.35 - $11.7 $1.56 Million - $2.49 Million	212,527 Added 10.53%	2,230,027 $21.1 Million
Q3 2018 Nov 14, 2018	BUY	$7.88 - $16.45 $15.9 Million - $33.2 Million	2,017,500 New	2,017,500 $16.1 Million

Others Institutions Holding ACIU

# of Institutions

Shares Held

28.2M

Call Options Held

150K

Put Options Held

12.4K

View Full List

About AC Immune SA

Ticker ACIU
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 83,413,504
Market Cap $296M
Description
AC Immune SA, a clinical stage biopharmaceutical company, discovers, designs, and develops medicines and diagnostic products for the prevention and treatment of neurodegenerative diseases associated with protein misfolding. Its SupraAntigen and Morphomer platforms are designed to generate vaccines, antibodies, and small molecules, which selectiv...

More about ACIU

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bvf Inc, based on Form 13F filings with the SEC.

News

Stay updated on Bvf Inc with notifications on news.

Account